Circulating Markers for Ischemic Heart Disease

Part of paid clinical trials in Farmington, Connecticut.

Sponsor
UConn Health
Study ID
NCT00762333
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or myocardial infarction.

Key Dates

Start date
Jun 30, 2007
Status verified
Jul 2025
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
550 participants (estimated)

Arms

  • Arm: Myocardial Infarction

Primary Outcome Measure

Hospitalization for acute myocardial infarction, stroke or death [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Connecticut Health CenterFarmingtonConnecticut06030
Bruce T. Liang, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Farmington, CT

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
University of Connecticut Health Center· Farmington, CT

Related Studies